Shanghai MicroPort Stock Soars 5.41%, Hits Intraday High of CNY 110.79

Shanghai MicroPort Endovascular MedTech Co., Ltd. has experienced a notable increase of 5.41% on March 10, 2026, reaching an intraday high of CNY 110.79. This performance stands out against the backdrop of the China Shanghai Composite, which only rose by 0.65% on the same day. Over the past month, Shanghai MicroPort has shown a robust growth of 11.05%, significantly outperforming the broader market, which saw a slight decline of 0.13%. Year-to-date, the stock has gained 19.95%, while the China Shanghai Composite has only managed a 3.89% increase. However, the company has faced challenges in its longer-term performance metrics, with a three-year decline of 14.05% and a five-year drop of 32.27%. Despite these fluctuations, the company maintains a market capitalization of CNY 11,950 million and a price-to-earnings ratio of 33.00. The stock also offers a dividend yield of 0.99%, reflecting its commitment to returning value to shareholders. As the company navigates its position in the pharmaceuticals and biotechnology sector, its recent performance highlights a significant moment in its trading activity.